Nextida® GC
Introducing Nextida GC
The first specific collagen peptide composition to be commercialized from Rousselot’s new Nextida platform, Nextida GC targets post-meal glucose spikes while boosting GLP-1 secretion—the natural way.
As consumer awareness of metabolic health continues to rise, and with the market experiencing rapid growth, Nextida GC offers a timely and innovative solution.
Explore the science behind Nextida GC to discover how it goes beyond collagen’s known benefits to open a new dimension of glucose control. Nextida GC is built and backed by science.
As consumer awareness of metabolic health continues to rise, and with the market experiencing rapid growth, Nextida GC offers a timely and innovative solution.
Explore the science behind Nextida GC to discover how it goes beyond collagen’s known benefits to open a new dimension of glucose control. Nextida GC is built and backed by science.
Benefits
Naturally target post-meal glucose spikes by boosting GLP-1 secretion
High variability in blood glucose levels can lead to a “sugar crash,” which includes food cravings, hunger and overeating.1,2,3,4 The hormone glucagon-like peptide-1 (GLP-1) helps balance glucose levels by triggering insulin release.5
To target GLP-1, Rousselot developed specialty collagen peptides in Nextida GC. Supplementation reduced post-meal glucose spikes by 42% on average in a placebo-controlled clinical study of 16 healthy individuals. At 10 grams, Nextida GC yielded a statistically significant GLP-1 increase in a healthy population when taken 30 minutes before a meal.6,7 The prediabetic subgroup also yielded statistically significant results at both 5 and 10 grams, showing promise for lower dosage levels in individuals with imbalanced glucose metabolism.
To target GLP-1, Rousselot developed specialty collagen peptides in Nextida GC. Supplementation reduced post-meal glucose spikes by 42% on average in a placebo-controlled clinical study of 16 healthy individuals. At 10 grams, Nextida GC yielded a statistically significant GLP-1 increase in a healthy population when taken 30 minutes before a meal.6,7 The prediabetic subgroup also yielded statistically significant results at both 5 and 10 grams, showing promise for lower dosage levels in individuals with imbalanced glucose metabolism.
Boosting GLP-1
Lower post-meal glucose peak
Improving insulin response
Benefits observed in scientific studies1,2,3,4,5,6,7
More information
Explore the details in our new brochures
Versatility
Flexible formats
Nextida GC works in a wide array of formats, easily consumed before meals, like powders, snacks, beverages and more. Nextida GC’s innate properties appeal to numerous consumers, ranging from healthy people interested in naturally boosting GLP-1 to those seeking glycemic control.
We help formulatePartner with us
Cobranding opportunities
Join leading companies who have leveraged the power of our collagen peptides to create successful branded products. Our co-branding program provides you with access to a trusted brand name, marketing materials and science support.
Contact us Resources
Additional information
Doctor Zagury on post-meal blood sugar spikes and supplement solutions
Expert insights on GLP-1 medications with Dr. Michael Murray
Doctor Michael Murray on metabolic health and natural solutions for glucose management
Webinar: Precision where it matters
ReferencesFind out more about the studies that support these findings on our dedicated scientific references page
- Blaak, E.E., et al., Impact of postprandial glycaemia on health and prevention of disease. Obesity Reviews, 2012. 13: p. 923-984.
- Ball, S.D., et al., Prolongation of satiety after low versus moderately high glycemic index meals in obese adolescents. Pediatrics, 2003. 111(3): p. 488-94.
- Ludwig, D.S., et al., High glycemic index foods, overeating, and obesity. Pediatrics, 1999. 103(3).
- Brand-Miller, J.C., et al., Glycemic index and obesity. The American Journal of Clinical Nutrition, 2002. 76(1): p. 281S-285S.
- Seino, Y., M. Fukushima, and D. Yabe, GIP and GLP-1, the two incretin hormones: Similarities and differences. J Diabetes Investig, 2010. 1(1-2): p. 8-23.
- Grasset, E., et al., A specific collagen hydrolysate improves postprandial glucose tolerance in normoglycemic and prediabetic mice and in a first proof of concept study in healthy, normoglycemic and prediabetic humans. Food Sci Nutr, 2024. 12(11): p. 9607-9620.
- Grasset, E., et al., A specific collagen hydrolysate improves postprandial glucose tolerance. Clinical Nutrition ESPEN, 2024. 63: p. 1310-1311.